Phil Lynch
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Phil Lynch
Chief Executive, Managing Director / Race Oncology
Phillip Lynch has over 15 years of experience in commercial leadership with Johnson & Johnson, bringing M&A experience and strong relationships in the Asia Pacific region.
He is also an experienced company director with a diverse background across corporate development, strategy, financial performance, marketing and governance.
Mr Lynch is a Business graduate from Monash University, completed postgraduate studies at the University of Virginia Darden Business School, and is a graduate of the Australian Institute of Company Directors.
He is also an experienced company director with a diverse background across corporate development, strategy, financial performance, marketing and governance.
Mr Lynch is a Business graduate from Monash University, completed postgraduate studies at the University of Virginia Darden Business School, and is a graduate of the Australian Institute of Company Directors.
Lists and Charts
Total Shareholder Return as at 29/11/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 267th | Race Oncology | 56% | 49% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Race Oncology | $4.0m |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Chief Executive, Managing Director, Race Oncology | 03 Nov 2020 |
